"Ultimately, high-quality evidence to guide regulatory and policy decision-making must come from adequately designed (and funded) RCTs [randomized controlled trials]–the highest attainable standard of medical evidence, which we owe to patients affected by drug-resistant tuberculosis to strive for and maintain."

Studies are underway to test whether giving a shot of BCG vaccine could protect doctors and nurses against COVID-19.

The World Health Organization Global TB Program is collating information on ongoing research projects at the interface of TB and COVID-19, with a view to support collaboration among researchers, as well as with policy makers.

Advocates call for a higher level of global coordination, transparency, and accountability to ensure sustainable and equitable access to testing.

The Stop TB Partnership released the first edition of its quarterly newsletter for 2020 detailing the progress of the Global Fund’s Strategic Initiative to Find the Missing People with TB.

Some regions may see deaths related to HIV, TB and malaria increase by up to 10, 20 and 36% respectively over five years due to the COVID-19 pandemic.

The International Union Against Tuberculosis and Lung Disease (The Union) released its April 2020 newsletter, summarizing the activities carried out during the month. The March 2020 issue of Public Health Action and the April 2020 issue of The International Journal of Tuberculosis and Lung Disease (IJTLD) are now online.

The International Union Against Tuberculosis and Lung Disease (The Union), in collaboration with its global community of members, launched an open-access webinar series on COVID-19 and its intersection with TB, tobacco control, lung disease and more.

Public Health Action is the free access, online journal of The International Union Against Tuberculosis and Lung Disease. The journal focuses on TB, lung health, non-communicable diseases and related public health issues.